Futura Medical PLC (AIM:FUM, OTC:FAMDF) CEO James Barder speaks to Thomas Warner from Proactive after launching innovative erectile dysfunction (ED) treatment gel Eroxon in the UK market.
Barder highlights the opportunity by the UK market and looks to the future, saying that there are "more launches coming."
He also expresses optimism about obtaining regulatory approval for OTC sales in the US by the end of June.